Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ip

Showing results (191-200 of 357) with videos related to

Pageof 36
Sort By:
Nephron|January 1, 1991
Effect of phosphatidylcholine on ultrafiltration in patients on continuous ambulatory peritoneal dialysisP C Chan, S C Tam, J D Robinson, et al.
JAMA Ophthalmology|February 25, 2018
Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti-Vascular Endothelial Growth Factor Medications: Secondary Outcomes From the SCORE2 Randomized Clinical TrialIngrid U Scott, Paul C VanVeldhuisen, Michael S Ip, et al.
Ophthalmology|January 27, 2009
SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusionIngrid U Scott, Paul C VanVeldhuisen, Neal L Oden, et al.
JAMA Ophthalmology|December 28, 2018
Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes With Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 StudyMichael S Ip, Neal L Oden, Ingrid U Scott, et al.
JAMA Ophthalmology|October 28, 2021
Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical TrialAhmad A Aref, Ingrid U Scott, Paul C VanVeldhuisen, et al.
Emerging Infectious Diseases|June 18, 2016
Highly Pathogenic Avian Influenza Viruses and Generation of Novel Reassortants, United States, 2014-2015Dong-Hun Lee, Justin Bahl, Mia Kim Torchetti, et al.
Chest|February 7, 2001
A community study of sleep-disordered breathing in middle-aged Chinese men in Hong KongM S Ip, B Lam, I J Lauder, et al.
Ophthalmology|April 7, 2009
SCORE Study Report 2: Interobserver agreement between investigator and reading center classification of retinal vein occlusion typeIngrid U Scott, Barbara A Blodi, Michael S Ip, et al.
Retina (Philadelphia, Pa.)|August 14, 2008
A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline featuresMichael S Ip, Susan B Bressler, Andrew N Antoszyk, et al.
The Angle Orthodontist|November 9, 2006
Dentofacial characteristics of Chinese obstructive sleep apnea patients in relation to obesity and severityHuie Ming Hou, Urban Hägg, Kim Sam, et al.
Pageof 36

Showing results (191-200 of 357) with videos related to

Sort By:
Pageof 36
Nephron|January 1, 1991
Effect of phosphatidylcholine on ultrafiltration in patients on continuous ambulatory peritoneal dialysisP C Chan, S C Tam, J D Robinson, et al.
JAMA Ophthalmology|February 25, 2018
Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti-Vascular Endothelial Growth Factor Medications: Secondary Outcomes From the SCORE2 Randomized Clinical TrialIngrid U Scott, Paul C VanVeldhuisen, Michael S Ip, et al.
Ophthalmology|January 27, 2009
SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusionIngrid U Scott, Paul C VanVeldhuisen, Neal L Oden, et al.
JAMA Ophthalmology|December 28, 2018
Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes With Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 StudyMichael S Ip, Neal L Oden, Ingrid U Scott, et al.
JAMA Ophthalmology|October 28, 2021
Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical TrialAhmad A Aref, Ingrid U Scott, Paul C VanVeldhuisen, et al.
Emerging Infectious Diseases|June 18, 2016
Highly Pathogenic Avian Influenza Viruses and Generation of Novel Reassortants, United States, 2014-2015Dong-Hun Lee, Justin Bahl, Mia Kim Torchetti, et al.
Chest|February 7, 2001
A community study of sleep-disordered breathing in middle-aged Chinese men in Hong KongM S Ip, B Lam, I J Lauder, et al.
Ophthalmology|April 7, 2009
SCORE Study Report 2: Interobserver agreement between investigator and reading center classification of retinal vein occlusion typeIngrid U Scott, Barbara A Blodi, Michael S Ip, et al.
Retina (Philadelphia, Pa.)|August 14, 2008
A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline featuresMichael S Ip, Susan B Bressler, Andrew N Antoszyk, et al.
The Angle Orthodontist|November 9, 2006
Dentofacial characteristics of Chinese obstructive sleep apnea patients in relation to obesity and severityHuie Ming Hou, Urban Hägg, Kim Sam, et al.
Pageof 36